On November 12, 2021 Dr Olga Kondrashova from the Medical Genomics Lab at QIMR Berghofer reported that it has been awarded a $650,740 Investigator grant from the National Health and Medical Research Council (Press release, QIMR Berghofer Medical Research Institute, NOV 12, 2021, View Source [SID1234595267]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr Kondrashova will use genomic technologies to study molecular portraits of cancers including ovarian and breast cancers with faulty DNA repair to better understand how to prevent drug resistance and treat each cancer most effectively.

This important work linking cancer genomics with patient treatment responses aims to improve cancer survival rates.

We are very grateful to the National Health and Medical Research Council for supporting our cancer genomics research initiatives.